Novel immunotherapies for rheumatoid arthritis.
作者信息
Richardson Sarah, Isaacs John
机构信息
Newcastle University, UK.
出版信息
Clin Med (Lond). 2013 Aug;13(4):391-4. doi: 10.7861/clinmedicine.13-4-391.
Abstract
摘要
相似文献
1
Novel immunotherapies for rheumatoid arthritis.类风湿关节炎的新型免疫疗法。
Clin Med (Lond). 2013 Aug;13(4):391-4. doi: 10.7861/clinmedicine.13-4-391.
2
Emerging immunotherapies for rheumatoid arthritis.类风湿关节炎的新兴免疫疗法。
Hum Vaccin Immunother. 2014;10(4):822-37. doi: 10.4161/hv.27910. Epub 2014 Feb 17.
3
Joint approach.联合方法。
Minn Med. 2009 Sep;92(9):22-5.
4
[Immunotherapy in rheumatoid arthritis; current status].[类风湿关节炎的免疫疗法；现状]
Ned Tijdschr Geneeskd. 1996 Jun 15;140(24):1255-9.
5
Introduction: new treatment paradigms in rheumatoid arthritis.引言：类风湿关节炎的新治疗模式
Am J Orthop (Belle Mead NJ). 2007 Mar;36(3 Suppl):2-3.
6
Immunotherapeutic approaches of rheumatic disorders.风湿性疾病的免疫治疗方法。
Acta Clin Belg. 1998 Jun;53(3):155-61.
7
Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.类风湿关节炎的抗肿瘤坏死因子α治疗。作用机制。
Eur Cytokine Netw. 1997 Sep;8(3):297-300.
8
[Anti-TNF-alpha monoclonal antibodies in the treatment of rheumatoid arthritis].[抗TNF-α单克隆抗体在类风湿关节炎治疗中的应用]
Rev Med Interne. 2000 Oct;21(10):854-62. doi: 10.1016/s0248-8663(00)00236-8.
9
New therapies for rheumatoid arthritis.类风湿关节炎的新疗法。
Clin Exp Immunol. 2005 May;140(2):195-204. doi: 10.1111/j.1365-2249.2005.02744.x.
10
Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis.抗肿瘤坏死因子治疗与类风湿关节炎中的 B 细胞。
Arthritis Res Ther. 2009;11(5):128. doi: 10.1186/ar2809. Epub 2009 Oct 6.
引用本文的文献
1
Mechanisms behind the Immunoregulatory Dialogue between Mesenchymal Stem Cells and Th17 Cells.间充质干细胞与 Th17 细胞免疫调节对话背后的机制。
Cells. 2020 Jul 10;9(7):1660. doi: 10.3390/cells9071660.
2
Personalized medicine in rheumatology.风湿病学中的个性化医疗。
Reumatologia. 2016;54(4):177-186. doi: 10.5114/reum.2016.62472. Epub 2016 Oct 5.
3
Pim-2/mTORC1 Pathway Shapes Inflammatory Capacity in Rheumatoid Arthritis Synovial Cells Exposed to Lipid Peroxidations.Pim-2/mTORC1通路塑造了暴露于脂质过氧化的类风湿关节炎滑膜细胞的炎症能力。
Biomed Res Int. 2015;2015:240210. doi: 10.1155/2015/240210. Epub 2015 May 4.
4
Effects of thapsigargin on the proliferation and survival of human rheumatoid arthritis synovial cells.毒胡萝卜素对人类风湿性关节炎滑膜细胞增殖和存活的影响。
ScientificWorldJournal. 2014 Feb 9;2014:605416. doi: 10.1155/2014/605416. eCollection 2014.
本文引用的文献
1
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial.托珠单抗单药治疗与阿达木单抗单药治疗类风湿关节炎（ADACTA）的随机、双盲、对照 4 期临床试验。
Lancet. 2013 May 4;381(9877):1541-50. doi: 10.1016/S0140-6736(13)60250-0. Epub 2013 Mar 18.
2
The role of biosimilars in the treatment of rheumatic diseases.生物类似药在风湿性疾病治疗中的作用。
Ann Rheum Dis. 2013 Mar;72(3):322-8. doi: 10.1136/annrheumdis-2012-202715. Epub 2012 Dec 19.
3
The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: a systematic review of the literature with a meta-analysis.抗 TNF 治疗在免疫介导的炎症性疾病中的免疫原性：系统评价文献荟萃分析。
Ann Rheum Dis. 2013 Dec;72(12):1947-55. doi: 10.1136/annrheumdis-2012-202220. Epub 2012 Dec 6.
4
Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis.基线类风湿因子和抗瓜氨酸化肽抗体血清型对利妥昔单抗临床反应的影响：一项荟萃分析。
Ann Rheum Dis. 2013 Mar;72(3):329-36. doi: 10.1136/annrheumdis-2011-201117. Epub 2012 Jun 11.
5
Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.接受肿瘤坏死因子拮抗剂治疗的患者发生皮肤和软组织感染（包括带状疱疹）的风险：英国风湿病学会生物制剂注册处的结果。
Ann Rheum Dis. 2013 Feb;72(2):229-34. doi: 10.1136/annrheumdis-2011-201108. Epub 2012 Apr 24.
6
The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register.抗 TNF 治疗对类风湿关节炎患者角质形成细胞皮肤癌发病率的影响：英国风湿病学会生物制剂登记处的纵向结果。
Ann Rheum Dis. 2012 Jun;71(6):869-74. doi: 10.1136/annrheumdis-2011-200622. Epub 2012 Jan 12.
7
Anti-TNF therapy.抗 TNF 治疗。
Best Pract Res Clin Rheumatol. 2011 Aug;25(4):549-67. doi: 10.1016/j.berh.2011.10.004.
8
Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register.类风湿关节炎患者发生脓毒性关节炎的风险和抗 TNF 治疗的效果：来自英国风湿病学会生物制剂注册处的结果。
Ann Rheum Dis. 2011 Oct;70(10):1810-4. doi: 10.1136/ard.2011.152769. Epub 2011 Jul 21.
9
Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis.类风湿关节炎中与利妥昔单抗相关的进行性多灶性白质脑病
Arch Neurol. 2011 Sep;68(9):1156-64. doi: 10.1001/archneurol.2011.103. Epub 2011 May 9.
10
Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.类风湿关节炎患者联合使用 DMARDs 对其接受抗 TNF 治疗的持续性的影响：来自英国风湿病学会生物制剂注册处的结果。
Ann Rheum Dis. 2011 Apr;70(4):583-9. doi: 10.1136/ard.2010.139774. Epub 2011 Feb 17.
Zotero 插件